BTC Health Limited (BTC.AX)
AUD 0.06
(1.69%)
AUD 0.06
(1.69%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 16.36 Thousand AUD | 0.0% |
| 2023 | - AUD | -86.04% |
| 2022 | - AUD | 395.07% |
| 2021 | - AUD | -93.49% |
| 2020 | - AUD | -7.29% |
| 2019 | - AUD | 52.89% |
| 2018 | - AUD | 629.35% |
| 2017 | - AUD | -59.97% |
| 2016 | - AUD | 527.17% |
| 2015 | - AUD | -27.22% |
| 2014 | - AUD | -58.64% |
| 2013 | 36.81 Thousand AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | -436 Thousand AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | -100.0% |
| 2008 | - AUD | -84.62% |
| 2007 | - AUD | -35.0% |
| 2006 | - AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| 2004 | -4.86 AUD | 0.0% |
| 2003 | - AUD | -100.0% |
| 2002 | 40 Thousand AUD | 0.0% |
| 2001 | - AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q4 | 603.4 Thousand AUD | 0.0% |
| 2024 Q2 | 1.97 Million AUD | 0.0% |
| 2024 FY | 16.36 Thousand AUD | 23.38% |
| 2023 FY | 13.26 Thousand AUD | -86.04% |
| 2023 Q4 | 9.91 Million AUD | 0.0% |
| 2023 Q2 | 263.78 Thousand AUD | 0.0% |
| 2022 FY | 95 Thousand AUD | 395.07% |
| 2022 Q4 | 24.62 Thousand AUD | 0.0% |
| 2022 Q2 | 70.37 Thousand AUD | 0.0% |
| 2021 FY | 19.19 Thousand AUD | -93.49% |
| 2021 Q4 | 249.00 AUD | 0.0% |
| 2021 Q2 | 18.94 Thousand AUD | 0.0% |
| 2020 Q4 | 112.99 Thousand AUD | 0.0% |
| 2020 FY | 294.6 Thousand AUD | -7.29% |
| 2020 Q2 | 181.61 Thousand AUD | 0.0% |
| 2019 Q4 | 212.54 Thousand AUD | 0.0% |
| 2019 FY | 317.76 Thousand AUD | 52.89% |
| 2019 Q2 | 105.21 Thousand AUD | 0.0% |
| 2018 FY | 207.83 Thousand AUD | 629.35% |
| 2018 Q2 | -187.88 Thousand AUD | 0.0% |
| 2018 Q4 | -164.27 Thousand AUD | 0.0% |
| 2017 Q2 | 5597.00 AUD | 0.0% |
| 2017 FY | 28.49 Thousand AUD | -59.97% |
| 2017 Q4 | 22.89 Thousand AUD | 0.0% |
| 2016 Q4 | 10.23 Thousand AUD | 0.0% |
| 2016 Q2 | 60.94 Thousand AUD | 0.0% |
| 2016 FY | 71.18 Thousand AUD | 527.17% |
| 2015 FY | 11.35 Thousand AUD | -27.22% |
| 2015 Q4 | 4316.00 AUD | 0.0% |
| 2015 Q2 | 7034.00 AUD | 0.0% |
| 2014 Q4 | 6874.00 AUD | 0.0% |
| 2014 FY | 15.59 Thousand AUD | -58.64% |
| 2014 Q2 | 8722.00 AUD | 0.0% |
| 2013 Q4 | 8900.00 AUD | 0.0% |
| 2013 Q2 | 28.81 Thousand AUD | 0.0% |
| 2013 Q3 | - AUD | -100.0% |
| 2013 Q1 | - AUD | 0.0% |
| 2013 FY | 37.71 Thousand AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2012 Q2 | - AUD | 0.0% |
| 2012 Q1 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2012 Q3 | - AUD | 0.0% |
| 2011 Q3 | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 Q2 | - AUD | 0.0% |
| 2011 Q1 | - AUD | 0.0% |
| 2010 Q2 | - AUD | 0.0% |
| 2010 Q3 | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2010 Q1 | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 Q1 | 500.00 AUD | 0.0% |
| 2009 Q2 | - AUD | -100.0% |
| 2009 Q3 | - AUD | 0.0% |
| 2009 FY | - AUD | -100.0% |
| 2008 Q1 | 3250.00 AUD | 0.0% |
| 2008 Q4 | 500.00 AUD | 0.0% |
| 2008 Q3 | 500.00 AUD | 0.0% |
| 2008 FY | 2000.00 AUD | -84.62% |
| 2008 Q2 | 500.00 AUD | -84.62% |
| 2007 Q4 | 3250.00 AUD | 0.0% |
| 2007 Q3 | 3250.00 AUD | 0.0% |
| 2007 Q2 | 3250.00 AUD | -35.0% |
| 2007 Q1 | 5000.00 AUD | 0.0% |
| 2007 FY | 13 Thousand AUD | -35.0% |
| 2006 Q2 | 5000.00 AUD | 0.0% |
| 2006 Q3 | 5000.00 AUD | 0.0% |
| 2006 FY | 20 Thousand AUD | 0.0% |
| 2006 Q4 | 5000.00 AUD | 0.0% |
| 2006 Q1 | - AUD | 0.0% |
| 2005 Q1 | - AUD | 0.0% |
| 2005 Q4 | - AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q3 | - AUD | 0.0% |
| 2005 Q2 | - AUD | 0.0% |
| 2004 Q1 | - AUD | 0.0% |
| 2004 Q2 | - AUD | 0.0% |
| 2004 FY | - AUD | 0.0% |
| 2004 Q4 | - AUD | 0.0% |
| 2004 Q3 | - AUD | 0.0% |
| 2003 Q3 | - AUD | 0.0% |
| 2003 FY | - AUD | -100.0% |
| 2003 Q1 | 10 Thousand AUD | 0.0% |
| 2003 Q2 | - AUD | -100.0% |
| 2003 Q4 | - AUD | 0.0% |
| 2002 Q1 | - AUD | 0.0% |
| 2002 Q4 | 10 Thousand AUD | 0.0% |
| 2002 FY | 40 Thousand AUD | 0.0% |
| 2002 Q2 | 10 Thousand AUD | 0.0% |
| 2002 Q3 | 10 Thousand AUD | 0.0% |
| 2001 Q4 | - AUD | 0.0% |
| 2001 Q2 | - AUD | 0.0% |
| 2001 Q1 | - AUD | 0.0% |
| 2001 FY | - AUD | 0.0% |
| 2001 Q3 | - AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AdAlta Limited | 1.5 Million AUD | 98.915% |
| Acrux Limited | -1.28 Million AUD | 101.274% |
| Amplia Therapeutics Limited | 4.01 Million AUD | 99.592% |
| Biome Australia Limited | 7.66 Million AUD | 99.787% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 99.781% |
| CSL Limited | 15.28 Billion AUD | 100.0% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 99.858% |
| Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | 99.979% |
| Noxopharm Limited | -534.81 Thousand AUD | 103.059% |
| PharmAust Limited | -1641.00 AUD | 1096.953% |
| Proteomics International Laboratories Limited | -1.12 Million AUD | 101.457% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 99.559% |
| PYC Therapeutics Limited | 22.05 Million AUD | 99.926% |
| Race Oncology Limited | 1.38 Million AUD | 98.823% |
| Starpharma Holdings Limited | 7.65 Million AUD | 99.786% |
| EZZ Life Science Holdings Limited | 50.94 Million AUD | 99.968% |
| Botanix Pharmaceuticals Limited | -6.55 Million AUD | 100.25% |
| Memphasys Limited | 1606.00 AUD | -918.68% |
| Nyrada Inc. | -5164.07 AUD | 416.804% |
| Anatara Lifesciences Ltd | -748.91 Thousand AUD | 102.185% |
| Telix Pharmaceuticals Limited | 308.5 Million AUD | 99.995% |
| Bio-Gene Technology Limited | -301.44 Thousand AUD | 105.427% |
| Zelira Therapeutics Limited | 10.28 Thousand AUD | -59.082% |
| Patrys Limited | 1.39 Million AUD | 98.827% |
| Dimerix Limited | 583.47 Thousand AUD | 97.196% |
| Neuren Pharmaceuticals Limited | 205.17 Million AUD | 99.992% |
| Orthocell Limited | 3.68 Million AUD | 99.556% |
| Imugene Limited | -5.83 Million AUD | 100.28% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 99.294% |
| Immutep Limited | 1.44 Million AUD | 98.867% |
| Arovella Therapeutics Limited | -25.97 Thousand AUD | 162.974% |
| Alterity Therapeutics Limited | 3.8 Million AUD | 99.57% |
| Nanollose Limited | -348.95 Thousand AUD | 104.688% |
| Invex Therapeutics Ltd | 1.21 Million AUD | 98.65% |
| NeuroScientific Biopharmaceuticals Limited | -91.33 Thousand AUD | 117.912% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | 98.693% |
| Biotron Limited | -40.49 Thousand AUD | 140.397% |
| Radiopharm Theranostics Limited | -21.3 Million AUD | 100.077% |
| Tissue Repair Ltd | 150.51 Thousand AUD | 89.13% |
| AnteoTech Limited | 460.39 Thousand AUD | 96.447% |
| Hexima Limited | - AUD | -Infinity% |
| Paradigm Biopharmaceuticals Limited | 56.81 Thousand AUD | 71.203% |
| Recce Pharmaceuticals Ltd | -366.76 Thousand AUD | 104.461% |
| Avecho Biotechnology Limited | -43.79 Thousand AUD | 137.356% |
| Actinogen Medical Limited | 9.93 Million AUD | 99.835% |
| Immuron Limited | 3.33 Million AUD | 99.51% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 99.37% |